Liver cirrhosis - A precancerous state. An analysis of not selected ambulatory patients;Die leberzirrhose als präkanzerose: Eine analyse an einem unausgewählten ambulanten patientengut

Verdauungskrankheiten

Volumn 21, Issue 3, 2003, Pages 129-134

  Grungreiff K ^a  

^a Internistische Facharztpraxis   (Germany)

Author keywords

Extrahepatic tumors; Hepatocellular carcinoma; Liver chirrhosis; Precancerose

Indexed keywords

ALCOHOL CONSUMPTION; AMBULATORY CARE; ARTICLE; BILE DUCT CARCINOMA; CANCER PREVENTION; CONTROLLED STUDY; EUROPE; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PRECANCER; PRIMARY PREVENTION; PROGNOSIS; UNITED STATES;

EID: 0038801479     PISSN: 0174738X     EISSN: None     Source Type: Journal    
DOI: 10.5414/vdp21129     Document Type: Article

References (32)

1. Almdal T.P., T.I.A. Sorensen: Incidence of parenchymal liver diseases in Denmark, 1981 to 1985: analysis of hospitalization registry. Hepatology 13, 650-655 (1991).
2. Anthony P.P.: Hepatocellular carcinoma: an overview. Histopathology 3, 109-118 (2001).
3. Becker U., H. Tonnesen, N. Kaas-Claesson, C. Gluud: Neuronal disturbances and fertility in chronic alcoholic women. Drug Alcohol Depend. 36, 74-78 (1989).
4. Becker U., H. Tonnesen, N. Kaas-Claesson, C. Gluud: Neuronal disturbances and fertility in chronic alcoholic women. Drug Alcohol Depend. 24, 74-78 (1991).
5. Bläker H., D. Theuer, H.F. Otto: Leberzirrhose und portale Hypertension. Der Radiologe 10, 833-839 (2001).
6. Blum H.E.: Multimodale Therapie des hepatozellulären Karzinoms. Der Hausarzt 49, 36-42 (2001).
7. Bolondi L., S. Sofia, S. Siringo, S. Gaiani, A. Casali, G. Zironi, F. Piscaglia, L. Gramantieri, M. Zanetti, M. Sherman: Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectivness analysis. Gut 48, 251-259 (2001).
8. Caselmann W.H., M. Alt: Hepatitis C virus infection as a major risk factor for hepatocellular carcinoma. J. Hepatol. 24 (S2), 61-66 (1996).
9. Caselmann W.H., U. Spengler, H.P. Fischer, T. Sauerbruch: Leberzirrhosen als Präkanzerosen. Internist 38, 928-936 (1997).
10. El-Serag H.B., A.C. Moson: Ricing incidence of hepatocellular carcinoma in the United States. N. Engl. J. Med. 340, 745-750 (1999).
11. Gebo K.A., G. Chander, M.W. Jenckes, K.G. Ghanem, H.F. Herlong, M.S. Torbenson, S.S. El Kamary, E.B. Bass: Screening tests for hepatocellular carcinoma in patients with chronic hepatitis C. A sytematic review. Hepatology 36, S84-S92 (2002).
12. Gluud C.: Testosteron and alcoholic cirrhosis. Epidemiologic, pathophysiologic and therapeutic studies. Dan. Med. Bull. 35, 564-575 (1988).
13. Grüngreiff K., D. Franke, F.D. Kleine: Infektionen bei der Leberzirrhose als Auslöser des Coma hepaticum. Intensivmed. 28, 188-195 (1991).
14. Hara K., S. Kolmo, H. Koga, M. Kaku, K. Tomono, S. Sakata, K. Kamatsu: Infections in patients with liver cirrhosis and hepatocellular carcinoma. Inter. Med 34, 491-495 (1995).
15. Henkler F., R. Kosby: Hepatitis B virus transcriptional activators: mechanisms and possible role in carcinogenesis. J. Viral. Hepat. 3, 109-121 (1996).
16. Kew M.C., M. Houghton, Q.L. Choo, G. Kew: Hepatitis C virus antibodies in southern African blacks with hepatocellular carcinoma. Lancet 335, 873-878 (1990).
17. Koike, K., K. Moriya, S. Iiono: High levels expression of hepatitis B virus HBX gene and hepatocarcinogenesis. Hepatology 19, 810-819 (1994).
18. Koike K., K. Moriya, S. Kimura: Role of hepatitis C virus in the development of hepatocellular carcinoma: transgenic approach to viral hepatocarcinogenesis. J. Gastroenterol. Hepatol. 17, 394-400 (2002).
19. Niu J., U. Kumar, J. Monjardino, R. Goldin, D. Rosin, H.C. Thoma: Hepatitis C virus replication in hepatocellular carcinoma. J. Clin. Pathol. 48, 880-882 (1995).
20. Noda K., H. Yoshihara, K. Suzuki, Y. Yamada, H. Kasahara, N. Hayashi, H. Fusamoto, T. Kamada: Progression of type C chronic hepatitis to liver cirrhosis and hepatocellular carcinoma - its relationship to alcohol drinking and the age of transfusion. Alc. Clin. Exp. Res. 20, 95A-100A (1996).
21. Nomura A.M.Y., L.N. Kolonel: Prostate cancer: a current perspective. Epidemiol. Rev. 13, 200-227 (1991).
22. Parkin M.D., F.L. Bray, S.S. Devesa: Cancer burden in the 2000. The global picture. Eur. J. Cancer 37, S4-S66 (2001).
23. Pessione F., M.J. Ramond, C. Njaponn, I. Erlinger, B. Rueff, D.C. Valla, F. Degos: Cigarette smoking and hepatitis lesions in patients with chronic hepatitis C. Hepatology 34, 121-125 (2001).
24. Pitot H.C.: Hepatocyte death in hepatocarcinogenesis. Hepatology 28, 1-5 (1998).
25. Ray R.B., K. Meyer, R. Ray: Suppression of apoptotic cell death by hepatitis C virus core protein. Virology 226, 176-182 (1996).
26. Rüster B., S. Zeuzem, W.K. Roth: Hepatitis C virus sequences encoding truncated core proteins detected in a hepatocellular carcinoma. Biochem. Biophys. Res. Com. 219, 911-915 (1996).
27. Shibata M., T. Morizane, T. Uchida, T. Yamogani, Y. Onozuka, M. Nakano, K. Mitramura, Y. Ueno: Irregular regeneration of hepatocytes and risk of hepatocellular carcinoma in chronic hepatitis-C-virus infection. Lancet 351, 1773-1777 (1998).
28. Simonetti R., C. Camma, F. Fiorelli, F. Politi, G. D'Amico, C. Pagliaro: Hepatocellular carcinoma: a worldwide problem and the major factor. Dig. Dis. Sci. 36, 962-972 (1991).
29. Sorensen H.T., S. Friis, H. Olsen, A.M. Thulstrup, L. Mellemkjer, M. Linet, D. Trichopoulos, H. Vilstrup, J. Olsen: Risk of liver and other types of cancer in patients with cirrhosis: a nationwide cohort study in Denmark. Hepatology 28, 921-925 (1998).
30. Thorgeirsson S.S., J.W. Grisham: Molecular pathogenesis of human hepatocellular carcinoma. Nature genetics 31, 339-343 (2002).
31. Weitberg A., D. Corverse: Oxygen radicals potentiate the genetic toxicity of tobacco specific nitrosamines. Clin. Genet. 43, 88-91 (1993).
32. Yusof M., M. Kakano, Y. Tanaka, E. Sodeyam, T. Kijosano: Persistence of viremia in patients. Scand. J. Gastroenterol. 2, 812-816 (1992).